← Open Payments lookup

LISA COCO: Open Payments

NPI 1841203726 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$42,154 in 125 payments from 20 companies in 2025. Trend: 2023 $30,189 · 2024 $12,430 · 2025 $42,154

Speaker / faculty: $22,017Travel & lodging: $8,531Honoraria: $8,484Food & beverage: $3,123
CompanyPaymentsAmount
Novo Nordisk Inc32$25,078
Xeris Pharmaceuticals, Inc.34$13,173
GlaxoSmithKline, LLC.7$2,561
Abbott Laboratories10$336
Amgen Inc.12$249
Lilly USA, LLC12$166
Ascendis Pharma Endocrinology Inc2$139
Medtronic, Inc.1$119
Corcept Therapeutics2$42
Amphastar Pharmaceuticals, Inc.2$39

Products named: Ozempic, GVOKE HYPOPEN, AREXVY, FREESTYLE LIBRE 3, Yorvipath, MINIMED 780G, EVENITY, TEPEZZA.

Industry payments across PA — which companies pay providers there.